{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:57:37Z","timestamp":1791187057215,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T00:00:00Z","timestamp":1332115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/ni.2228","type":"journal-article","created":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T15:46:11Z","timestamp":1332171971000},"page":"352-357","source":"Crossref","is-referenced-by-count":405,"title":["A role for the NLRP3 inflammasome in metabolic diseases\u2014did Warburg miss inflammation?"],"prefix":"10.1038","volume":"13","author":[{"given":"Haitao","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny P-Y","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A J","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,19]]},"reference":[{"key":"BFni2228_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil, G.S. Inflammation and metabolic disorders. Nature 444, 860\u2013867 (2006).","journal-title":"Nature"},{"key":"BFni2228_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrendo.2009.62","volume":"5","author":"B F\u00e8ve","year":"2009","unstructured":"F\u00e8ve, B. & Bastard, J.P. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 5, 305\u2013311 (2009).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFni2228_CR3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","volume":"223","author":"WP Arend","year":"2008","unstructured":"Arend, W.P., Palmer, G. & Gabay, C. IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 223, 20\u201338 (2008).","journal-title":"Immunol. Rev."},{"key":"BFni2228_CR4","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa065213","volume":"356","author":"CM Larsen","year":"2007","unstructured":"Larsen, C.M. et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517\u20131526 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFni2228_CR5","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1210\/jc.2010-1170","volume":"96","author":"TL Stanley","year":"2011","unstructured":"Stanley, T.L. et al. TNF-\u03b1 antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J. Clin. Endocrinol. Metab. 96, E146\u2013E150 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFni2228_CR6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.2009.05287.x","volume":"1193","author":"MA Gonzalez-Gay","year":"2010","unstructured":"Gonzalez-Gay, M.A., Gonzalez-Juanatey, C., Vazquez-Rodriguez, T.R., Miranda-Filloy, J.A. & Llorca, J. Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-\u03b1 therapy. Ann. NY Acad. Sci. 1193, 153\u2013159 (2010).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFni2228_CR7","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/jama.2011.878","volume":"305","author":"DH Solomon","year":"2011","unstructured":"Solomon, D.H. et al. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. J. Am. Med. Assoc. 305, 2525\u20132531 (2011).","journal-title":"J. Am. Med. Assoc."},{"key":"BFni2228_CR8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821\u2013832 (2010).","journal-title":"Cell"},{"key":"BFni2228_CR9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.coi.2011.07.005","volume":"23","author":"BR Barker","year":"2011","unstructured":"Barker, B.R., Taxman, D.J. & Ting, J.P. Cross-regulation between the IL-1\u03b2\/IL-18 processing inflammasome and other inflammatory cytokines. Curr. Opin. Immunol. 23, 591\u2013597 (2011).","journal-title":"Curr. Opin. Immunol."},{"key":"BFni2228_CR10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.1831","volume":"11","author":"R Zhou","year":"2010","unstructured":"Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136\u2013140 (2010).","journal-title":"Nat. Immunol."},{"key":"BFni2228_CR11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cmet.2010.11.011","volume":"12","author":"R Stienstra","year":"2010","unstructured":"Stienstra, R. et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 12, 593\u2013605 (2010).","journal-title":"Cell Metab."},{"key":"BFni2228_CR12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","volume":"17","author":"B Vandanmagsar","year":"2011","unstructured":"Vandanmagsar, B. et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179\u2013188 (2011).","journal-title":"Nat. Med."},{"key":"BFni2228_CR13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","volume":"12","author":"H Wen","year":"2011","unstructured":"Wen, H. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408\u2013415 (2011).","journal-title":"Nat. Immunol."},{"key":"BFni2228_CR14","doi-asserted-by":"crossref","first-page":"15324","DOI":"10.1073\/pnas.1100255108","volume":"108","author":"R Stienstra","year":"2011","unstructured":"Stienstra, R. et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 108, 15324\u201315329 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni2228_CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.200903124","volume":"187","author":"M Lamkanfi","year":"2009","unstructured":"Lamkanfi, M. et al. Glyburide inhibits the cryopyrin\/Nalp3 inflammasome. J. Cell Biol. 187, 61\u201370 (2009).","journal-title":"J. Cell Biol."},{"key":"BFni2228_CR16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nrendo.2009.271","volume":"6","author":"T Mandrup-Poulsen","year":"2010","unstructured":"Mandrup-Poulsen, T., Pickersgill, L. & Donath, M.Y. Blockade of interleukin 1 in type 1 diabetes mellitus. Nat. Rev. Endocrinol. 6, 158\u2013166 (2010).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFni2228_CR17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters, S.L. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes. Nat. Immunol. 11, 897\u2013904 (2010).","journal-title":"Nat. Immunol."},{"key":"BFni2228_CR18","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","volume":"91","author":"P Westermark","year":"2011","unstructured":"Westermark, P., Andersson, A. & Westermark, G.T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. 91, 795\u2013826 (2011).","journal-title":"Physiol. Rev."},{"key":"BFni2228_CR19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","volume":"110","author":"K Maedler","year":"2002","unstructured":"Maedler, K. et al. Glucose-induced beta cell production of IL-1\u03b2 contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 110, 851\u2013860 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFni2228_CR20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature09782","volume":"469","author":"B Levine","year":"2011","unstructured":"Levine, B., Mizushima, N. & Virgin, H.W. Autophagy in immunity and inflammation. Nature 469, 323\u2013335 (2011).","journal-title":"Nature"},{"key":"BFni2228_CR21","doi-asserted-by":"crossref","unstructured":"The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661\u2013678 (2007).","DOI":"10.1038\/nature05911"},{"key":"BFni2228_CR22","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/ng2032","volume":"39","author":"JD Rioux","year":"2007","unstructured":"Rioux, J.D. et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39, 596\u2013604 (2007).","journal-title":"Nat. Genet."},{"key":"BFni2228_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/ng1954","volume":"39","author":"J Hampe","year":"2007","unstructured":"Hampe, J. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207\u2013211 (2007).","journal-title":"Nat. Genet."},{"key":"BFni2228_CR24","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cell.2010.05.009","volume":"141","author":"K Cadwell","year":"2010","unstructured":"Cadwell, K. et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141, 1135\u20131145 (2010).","journal-title":"Cell"},{"key":"BFni2228_CR25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nature07383","volume":"456","author":"T Saitoh","year":"2008","unstructured":"Saitoh, T. et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1\u03b2 production. Nature 456, 264\u2013268 (2008).","journal-title":"Nature"},{"key":"BFni2228_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ni.1980","volume":"12","author":"K Nakahira","year":"2011","unstructured":"Nakahira, K. et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222\u2013230 (2011).","journal-title":"Nat. Immunol."},{"key":"BFni2228_CR27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou, R., Yazdi, A.S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221\u2013225 (2011).","journal-title":"Nature"},{"key":"BFni2228_CR28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.04.005","volume":"11","author":"L Yang","year":"2010","unstructured":"Yang, L., Li, P., Fu, S., Calay, E.S. & Hotamisligil, G.S. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 11, 467\u2013478 (2010).","journal-title":"Cell Metab."},{"key":"BFni2228_CR29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim, J., Kundu, M., Viollet, B. & Guan, K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132\u2013141 (2011).","journal-title":"Nat. Cell Biol."},{"key":"BFni2228_CR30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1126\/science.1196371","volume":"331","author":"DF Egan","year":"2011","unstructured":"Egan, D.F. et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331, 456\u2013461 (2011).","journal-title":"Science"},{"key":"BFni2228_CR31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev-immunol-031210-101405","volume":"29","author":"BK Davis","year":"2011","unstructured":"Davis, B.K., Wen, H. & Ting, J.P. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29, 707\u2013735 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"BFni2228_CR32","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","volume":"30","author":"Y Chung","year":"2009","unstructured":"Chung, Y. et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30, 576\u2013587 (2009).","journal-title":"Immunity"},{"key":"BFni2228_CR33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1074-7613(00)80378-7","volume":"7","author":"D Robinson","year":"1997","unstructured":"Robinson, D. et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NF\u03baB. Immunity 7, 571\u2013581 (1997).","journal-title":"Immunity"},{"key":"BFni2228_CR34","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","volume":"8","author":"NJ Wilson","year":"2007","unstructured":"Wilson, N.J. et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8, 950\u2013957 (2007).","journal-title":"Nat. Immunol."},{"key":"BFni2228_CR35","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez, E.V., Napolitani, G., Lanzavecchia, A. & Sallusto, F. Interleukins 1\u03b2 and 6 but not transforming growth factor-\u03b2 are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942\u2013949 (2007).","journal-title":"Nat. Immunol."},{"key":"BFni2228_CR36","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nm.2002","volume":"15","author":"M Feuerer","year":"2009","unstructured":"Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930\u2013939 (2009).","journal-title":"Nat. Med."},{"key":"BFni2228_CR37","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm.1964","volume":"15","author":"S Nishimura","year":"2009","unstructured":"Nishimura, S. et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15, 914\u2013920 (2009).","journal-title":"Nat. Med."},{"key":"BFni2228_CR38","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm.2001","volume":"15","author":"S Winer","year":"2009","unstructured":"Winer, S. et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 15, 921\u2013929 (2009).","journal-title":"Nat. Med."},{"key":"BFni2228_CR39","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4049\/jimmunol.1000021","volume":"185","author":"H Yang","year":"2010","unstructured":"Yang, H. et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J. Immunol. 185, 1836\u20131845 (2010).","journal-title":"J. Immunol."},{"key":"BFni2228_CR40","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nm.2353","volume":"17","author":"DA Winer","year":"2011","unstructured":"Winer, D.A. et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 17, 610\u2013617 (2011).","journal-title":"Nat. Med."},{"key":"BFni2228_CR41","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nm1102-1218","volume":"8","author":"CJ Binder","year":"2002","unstructured":"Binder, C.J. et al. Innate and acquired immunity in atherogenesis. Nat. Med. 8, 1218\u20131226 (2002).","journal-title":"Nat. Med."},{"key":"BFni2228_CR42","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson, G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685\u20131695 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFni2228_CR43","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","volume":"23","author":"H Kirii","year":"2003","unstructured":"Kirii, H. et al. Lack of interleukin-1\u03b2 decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23, 656\u2013660 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFni2228_CR44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.CIR.97.3.242","volume":"97","author":"R Elhage","year":"1998","unstructured":"Elhage, R. et al. Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation 97, 242\u2013244 (1998).","journal-title":"Circulation"},{"key":"BFni2228_CR45","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1126\/science.1160794","volume":"322","author":"G Sabio","year":"2008","unstructured":"Sabio, G. et al. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322, 1539\u20131543 (2008).","journal-title":"Science"},{"key":"BFni2228_CR46","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.2513","volume":"17","author":"H Ellingsgaard","year":"2011","unstructured":"Ellingsgaard, H. et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and \u03b1 cells. Nat. Med. 17, 1481\u20131489 (2011).","journal-title":"Nat. Med."},{"key":"BFni2228_CR47","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357\u20131361 (2010).","journal-title":"Nature"},{"key":"BFni2228_CR48","doi-asserted-by":"crossref","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","volume":"5","author":"K Rajam\u00e4ki","year":"2010","unstructured":"Rajam\u00e4ki, K. et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE 5, e11765 (2010).","journal-title":"PLoS ONE"},{"key":"BFni2228_CR49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"BFni2228_CR50","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1156995","volume":"320","author":"C Dostert","year":"2008","unstructured":"Dostert, C. et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674\u2013677 (2008).","journal-title":"Science"},{"key":"BFni2228_CR51","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","volume":"9","author":"V Hornung","year":"2008","unstructured":"Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847\u2013856 (2008).","journal-title":"Nat. Immunol."},{"key":"BFni2228_CR52","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","volume":"453","author":"SC Eisenbarth","year":"2008","unstructured":"Eisenbarth, S.C., Colegio, O.R., O'Connor, W., Sutterwala, F.S. & Flavell, R.A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453, 1122\u20131126 (2008).","journal-title":"Nature"},{"key":"BFni2228_CR53","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1038\/cddis.2011.18","volume":"2","author":"P Menu","year":"2011","unstructured":"Menu, P. et al. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome. Cell Death Dis. 2, e137 (2011).","journal-title":"Cell Death Dis."},{"key":"BFni2228_CR54","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1084\/jem.20100050","volume":"207","author":"IC Allen","year":"2010","unstructured":"Allen, I.C. et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 207, 1045\u20131056 (2010).","journal-title":"J. Exp. Med."},{"key":"BFni2228_CR55","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2010.03.003","volume":"32","author":"MH Zaki","year":"2010","unstructured":"Zaki, M.H. et al. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379\u2013391 (2010).","journal-title":"Immunity"},{"key":"BFni2228_CR56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-immunol-030409-101311","volume":"28","author":"KL Rock","year":"2010","unstructured":"Rock, K.L., Latz, E., Ontiveros, F. & Kono, H. The sterile inflammatory response. Annu. Rev. Immunol. 28, 321\u2013342 (2010).","journal-title":"Annu. Rev. Immunol."},{"key":"BFni2228_CR57","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","volume":"9","author":"A So","year":"2007","unstructured":"So, A., De Smedt, T., Revaz, S. & Tschopp, J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res. Ther. 9, R28 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"BFni2228_CR58","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1136\/ard.2009.108936","volume":"68","author":"R Terkeltaub","year":"2009","unstructured":"Terkeltaub, R. et al. The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study. Ann. Rheum. Dis. 68, 1613\u20131617 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"BFni2228_CR59","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1002\/art.27600","volume":"62","author":"A So","year":"2010","unstructured":"So, A. et al. Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study. Arthritis Rheum. 62, 3064\u20133076 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFni2228_CR60","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/ard.2010.144063","volume":"70","author":"N Schlesinger","year":"2011","unstructured":"Schlesinger, N. et al. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study. Ann. Rheum. Dis. 70, 1264\u20131271 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFni2228_CR61","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.immuni.2011.10.016","volume":"35","author":"K Labb\u00e9","year":"2011","unstructured":"Labb\u00e9, K., McIntire, C.R., Doiron, K., Leblanc, P.M. & Saleh, M. Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome. Immunity 35, 897\u2013907 (2011).","journal-title":"Immunity"},{"key":"BFni2228_CR62","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nature10394","volume":"477","author":"EM Kofoed","year":"2011","unstructured":"Kofoed, E.M. & Vance, R.E. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 477, 592\u2013595 (2011).","journal-title":"Nature"},{"key":"BFni2228_CR63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10072","volume":"474","author":"LE Sander","year":"2011","unstructured":"Sander, L.E. et al. Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature 474, 385\u2013389 (2011).","journal-title":"Nature"},{"key":"BFni2228_CR64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni.1824","volume":"11","author":"H Poeck","year":"2010","unstructured":"Poeck, H. et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1\u03b2 production. Nat. Immunol. 11, 63\u201369 (2010).","journal-title":"Nat. Immunol."},{"key":"BFni2228_CR65","doi-asserted-by":"crossref","first-page":"18375","DOI":"10.1074\/jbc.M413169200","volume":"280","author":"BJ Conti","year":"2005","unstructured":"Conti, B.J. et al. CATERPILLER 16.2 (CLR16.2), a novel NBD\/LRR family member that negatively regulates T cell function. J. Biol. Chem. 280, 18375\u201318385 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFni2228_CR66","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.immuni.2009.02.005","volume":"30","author":"IC Allen","year":"2009","unstructured":"Allen, I.C. et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30, 556\u2013565 (2009).","journal-title":"Immunity"},{"key":"BFni2228_CR67","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.1100613","volume":"187","author":"F Bauernfeind","year":"2011","unstructured":"Bauernfeind, F. et al. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J. Immunol. 187, 613\u2013617 (2011).","journal-title":"J. Immunol."},{"key":"BFni2228_CR68","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2011.03.015","volume":"34","author":"M Kool","year":"2011","unstructured":"Kool, M. et al. An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity 34, 527\u2013540 (2011).","journal-title":"Immunity"},{"key":"BFni2228_CR69","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.immuni.2011.03.019","volume":"34","author":"E Kuroda","year":"2011","unstructured":"Kuroda, E. et al. Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity 34, 514\u2013526 (2011).","journal-title":"Immunity"},{"key":"BFni2228_CR70","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","volume":"115","author":"CM Krawczyk","year":"2010","unstructured":"Krawczyk, C.M. et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115, 4742\u20134749 (2010).","journal-title":"Blood"},{"key":"BFni2228_CR71","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu, P.P. & Sabatini, D.M. Cancer cell metabolism: Warburg and beyond. Cell 134, 703\u2013707 (2008).","journal-title":"Cell"},{"key":"BFni2228_CR72","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.febslet.2011.05.008","volume":"585","author":"GM Tannahill","year":"2011","unstructured":"Tannahill, G.M. & O'Neill, L.A. The emerging role of metabolic regulation in the functioning of Toll-like receptors and the NOD-like receptor Nlrp3. FEBS Lett. 585, 1568\u20131572 (2011).","journal-title":"FEBS Lett."},{"key":"BFni2228_CR73","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer, G. & Pouyssegur, J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13, 472\u2013482 (2008).","journal-title":"Cancer Cell"},{"key":"BFni2228_CR74","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature06734","volume":"452","author":"HR Christofk","year":"2008","unstructured":"Christofk, H.R. et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230\u2013233 (2008).","journal-title":"Nature"},{"key":"BFni2228_CR75","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","volume":"145","author":"W Luo","year":"2011","unstructured":"Luo, W. et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145, 732\u2013744 (2011).","journal-title":"Cell"},{"key":"BFni2228_CR76","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature04871","volume":"441","author":"J Pouyss\u00e9gur","year":"2006","unstructured":"Pouyss\u00e9gur, J., Dayan, F. & Mazure, N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441, 437\u2013443 (2006).","journal-title":"Nature"},{"key":"BFni2228_CR77","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","volume":"112","author":"T Cramer","year":"2003","unstructured":"Cramer, T. et al. HIF-1\u03b1 is essential for myeloid cell-mediated inflammation. Cell 112, 645\u2013657 (2003).","journal-title":"Cell"},{"key":"BFni2228_CR78","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4049\/jimmunol.0901698","volume":"185","author":"JC Rodr\u00edguez-Prados","year":"2010","unstructured":"Rodr\u00edguez-Prados, J.C. et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J. Immunol. 185, 605\u2013614 (2010).","journal-title":"J. Immunol."},{"key":"BFni2228_CR79","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.4049\/jimmunol.178.12.7516","volume":"178","author":"C Peyssonnaux","year":"2007","unstructured":"Peyssonnaux, C. et al. Cutting edge: Essential role of hypoxia inducible factor-1\u03b1 in development of lipopolysaccharide-induced sepsis. J. Immunol. 178, 7516\u20137519 (2007).","journal-title":"J. Immunol."},{"key":"BFni2228_CR80","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nature03985","volume":"437","author":"SE Calvano","year":"2005","unstructured":"Calvano, S.E. et al. A network-based analysis of systemic inflammation in humans. Nature 437, 1032\u20131037 (2005).","journal-title":"Nature"},{"key":"BFni2228_CR81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","volume":"7","author":"MA Selak","year":"2005","unstructured":"Selak, M.A. et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-\u03b1 prolyl hydroxylase. Cancer Cell 7, 77\u201385 (2005).","journal-title":"Cancer Cell"},{"key":"BFni2228_CR82","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1089\/ars.2007.1825","volume":"10","author":"K Nishi","year":"2008","unstructured":"Nishi, K. et al. LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner. Antioxid. Redox Signal. 10, 983\u2013995 (2008).","journal-title":"Antioxid. Redox Signal."},{"key":"BFni2228_CR83","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.bcp.2010.08.003","volume":"80","author":"F Pistollato","year":"2010","unstructured":"Pistollato, F. et al. Hypoxia and succinate antagonize 2-deoxyglucose effects on glioblastoma. Biochem. Pharmacol. 80, 1517\u20131527 (2010).","journal-title":"Biochem. Pharmacol."},{"key":"BFni2228_CR84","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/cdd.2010.27","volume":"17","author":"A Garedew","year":"2010","unstructured":"Garedew, A., Henderson, S.O. & Moncada, S. Activated macrophages utilize glycolytic ATP to maintain mitochondrial membrane potential and prevent apoptotic cell death. Cell Death Differ. 17, 1540\u20131550 (2010).","journal-title":"Cell Death Differ."},{"key":"BFni2228_CR85","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","volume":"146","author":"EV Dang","year":"2011","unstructured":"Dang, E.V. et al. Control of TH17\/Treg balance by hypoxia-inducible factor 1. Cell 146, 772\u2013784 (2011).","journal-title":"Cell"},{"key":"BFni2228_CR86","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.20110278","volume":"208","author":"LZ Shi","year":"2011","unstructured":"Shi, L.Z. et al. HIF1\u03b1-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367\u20131376 (2011).","journal-title":"J. Exp. Med."},{"issue":"Suppl 3","key":"BFni2228_CR87","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/diabetes.53.suppl_3.S97","volume":"53","author":"B Emanuelli","year":"2004","unstructured":"Emanuelli, B., Glondu, M., Filloux, C., Peraldi, P. & Van Obberghen, E. The potential role of SOCS-3 in the interleukin-1\u03b2-induced desensitization of insulin signaling in pancreatic beta-cells. Diabetes 53 Suppl 3, S97\u2013S103 (2004).","journal-title":"Diabetes"},{"key":"BFni2228_CR88","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2119\/2007-00119.Tilg","volume":"14","author":"H Tilg","year":"2008","unstructured":"Tilg, H. & Moschen, A.R. Inflammatory mechanisms in the regulation of insulin resistance. Mol. Med. 14, 222\u2013231 (2008).","journal-title":"Mol. Med."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ni.2228.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni.2228","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni.2228.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:39:33Z","timestamp":1684453173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni.2228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,19]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["BFni2228"],"URL":"https:\/\/doi.org\/10.1038\/ni.2228","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,19]]}}}